Max Robotics — Global Service Robot Directory + US Certification

About

Thomas Bartel is a pioneering cardiac surgeon whose research has centered on advancing robotic totally endoscopic coronary artery bypass grafting (TECAB), a minimally invasive alternative to traditional open-heart surgery. Over the past two decades, his work has been instrumental in evolving TECAB from a single-vessel procedure into a viable option for multivessel coronary artery disease, pushing the boundaries of closed-chest surgical treatment. His most cited paper, a 2019 systematic review (47 citations), synthesizes clinical outcomes from two decades of TECAB, establishing a benchmark for the field. Another key study (30 citations) details the first steps toward double-vessel bypass grafting, while his 2016 long-term results paper (23 citations) provides crucial data on durability and patient survival, addressing a critical gap in the literature. Bartel has also contributed to innovative techniques, such as arterial Y-graft configurations for multivessel revascularization, and has tackled complex complications, including the endoscopic removal of dislodged cardiac devices. His cumulative work has not only refined surgical protocols but also demonstrated that robotic cardiac surgery can achieve outcomes comparable to conventional methods, making him a leading figure in minimally invasive coronary care.